DROMEINTER
⚠️ High Risk
FEI: 3020047550 • Tegucigalpa, Francisco Morazan • HONDURAS
FEI Number
3020047550
Location
Tegucigalpa, Francisco Morazan
Country
HONDURASAddress
Av Republica De Ecuador, , Tegucigalpa, Francisco Morazan, Honduras
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
LACKS FIRM
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.
LACKS N/C
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.
USUAL NAME
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(1) of the FD&C Act in that the label fails to bear the common or usual name of the food, if any there be.
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
DIRSEXMPT
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 10/21/2022 | 62GAC41IBUPROFEN (ANTI-INFLAMMATORY) | 27DRUG GMPS | Division of Southeast Imports (DSEI) |
| 10/21/2022 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 27DRUG GMPS | Division of Southeast Imports (DSEI) |
| 9/19/2022 | 54ACC05VITAMIN B12 (CYANOCOBALAMIN) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/5/2022 | 60IBR12SODIUM CITRATE (ALKALIZER) | Division of Southwest Imports (DSWI) | |
| 8/5/2022 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Division of Southwest Imports (DSWI) |
| 6/8/2022 | 65JAK21MEDROXYPROGESTERONE ACETATE (PROGESTIN) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/12/2022 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 5/10/2022 | 62KAC11NITAZOXANIDE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/10/2022 | 62GAC41IBUPROFEN (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/10/2022 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/9/2022 | 60LAA01ACETAMINOPHEN (ANALGESIC) | Division of Northeast Imports (DNEI) | |
| 4/29/2022 | 60LAA01ACETAMINOPHEN (ANALGESIC) | Division of Southwest Imports (DSWI) | |
| 4/29/2022 | 60LAA01ACETAMINOPHEN (ANALGESIC) | Division of Southwest Imports (DSWI) | |
| 4/21/2022 | 54AYA90MULTIPLE VITAMINS (MVI-12 VITAMIN COMBO) (VITAMIN) | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is DROMEINTER's FDA import refusal history?
DROMEINTER (FEI: 3020047550) has 14 FDA import refusal record(s) in our database, spanning from 4/21/2022 to 10/21/2022.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. DROMEINTER's FEI number is 3020047550.
What types of violations has DROMEINTER received?
DROMEINTER has been cited for 11 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about DROMEINTER come from?
All FDA import refusal data for DROMEINTER is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.